17 January 2023 in Cancer Discovery
Glioblastoma (GBM) constitutes the most lethal primary brain tumor for which immunotherapy has provided limited benefit. The unique brain immune landscape is reflected in a complex tumor immune microenvironment (TIME) in GBM. Here, single-cell sequencing of the GBM TIME revealed that microglia were under severe oxidative stress, which induced nuclear receptor subfamily 4 group A member 2 (NR4A2)–dependent transcriptional activity in microglia. Heterozygous Nr4a2 (Nr4a2+/−) or CX3CR1+ myeloid cell–specific Nr4a2 (Nr4a2fl/flCx3cr1Cre) genetic targeting reshaped microglia plasticity in vivo by reducing alternatively activated microglia and enhancing antigen presentation capacity for CD8+ T cells in GBM. In microglia, NR4A2 activated squalene monooxygenase (SQLE) to dysregulate cholesterol homeostasis. Pharmacologic NR4A2 inhibition attenuated the protumorigenic TIME, and targeting the NR4A2 or SQLE enhanced the therapeutic efficacy of immune-checkpoint blockade in vivo. Collectively, oxidative stress promotes tumor growth through NR4A2–SQLE activity in microglia, informing novel immune therapy paradigms in brain cancer. Significance: Metabolic reprogramming of microglia in GBM informs synergistic vulnerabilities for immune-checkpoint blockade therapy in this immunologically cold brain tumor. This article is highlighted in the In This Issue feature, p. 799
26 February 2021 in Science Advances
Plasma cells shape the mesenchymal identity of ovarian cancers through exosome-mediated miR-330-3p/JAM2 axis.
1 January 2022 in Brazilian Journal of Medical and Biological Research
Although metastasis is the major cause of death in cervical cancer, the mechanism of metastasis is still unclear. The mRNA expression and protein level of latent transforming growth factor beta binding protein 1 (LTBP1) were detected in tumor tissues and paracancerous tissues from in-house samples. Cell proliferation, cell cycle, migration, and in vivo metastasis were determined after LTBP1 was knocked down. Then, 13 drugs were screened, and the changes in cell apoptosis and proliferation and tumor metastasis were detected after drug treatment in shRNA cells. In our in-house samples, LTBP1 was lowly expressed in cervical cancer tissues. After LTBP1 knockdown, cell proliferation was increased, and the ability of in vitro migration and in vivo metastasis was enhanced. At the same time, the proportion of myeloid derived suppressor cells (MDSC) in situ increased, the proportion of T cells decreased, and transforming growth factor beta-1 (TGFβ1) signaling was activated. After carboplatin treatment, LTBP1 shRNA cell line apoptosis increased, metastasis in vivo was limited, and the proportion of MDSC in situ decreased. LTBP1 was lowly expressed in cervical cancer, and the inhibition of LTBP1 can improve the malignant degree of the tumor, and this process can be blocked by carboplatin.
24 November 2025 in Hepatology Communications
Background: Liver regeneration is a highly complex biological process, and the molecular mechanisms governing regenerative capacity exhibit significant divergence across distinct developmental stages. This study aimed to developmentally conserve pro-regenerative regulators of the liver and elucidate their mechanistic roles in the developmental stages of liver regeneration. Methods: Wild-type mice at distinct developmental stages, including 1-month-old (adolescent), 4-month-old (adult), 12-month-old (middle-aged), and 20-month-old (aged), underwent sham surgery or 2/3 partial hepatectomy. RNA sequencing and scRNA-seq identified the target gene and spatial expression. Hepatocyte proliferation was assessed by Ki-67, PCNA staining, and hematoxylin and eosin staining. Functional and mechanistic studies have employed bioinformatics, IF, coimmunoprecipitation, quantitative real-time PCR, and small-molecule inhibition. Results: RNA sequencing across age groups identified leukocyte cell–derived chemotaxin 2 (LECT2) as a functionally significant mediator in liver regeneration processes. Longitudinal assessment of murine liver regeneration models and patients who underwent hepatectomy revealed dynamic LECT2 expression patterns. LECT2 expression positively correlated with regeneration markers Ki-67 and PCNA. Lect2 -KO mice in 4 age groups exhibited impaired liver regeneration. Immunofluorescence staining and single-cell RNA sequencing demonstrated predominant hepatocyte-specific expression of LECT2. Hepatocyte-specific Lect2 knockout significantly impaired liver regeneration following 2/3 partial hepatectomy. Interestingly, there appeared to be no difference in the level of regeneration in mice with suppressed A Disintegrin and Metalloproteinase Domain 10 (ADAM10) expression despite Lect2 overexpression. Mechanistic investigations revealed that LECT2 potentiates hepatic regeneration by activating the ADAM10-NOTCH signaling pathway. Finally, our in vivo therapeutic model demonstrated that adeno-associated virus–mediated Lect2 overexpression significantly enhanced the posthepatectomy regenerative capacity. Conclusions: LECT2 promotes liver regeneration across developmental stages by activating the ADAM10-NOTCH signaling pathway, providing a promising therapeutic target for enhancing hepatic repair.
7 April 2026 in Cancer Discovery
Despite successful immuno-oncology therapies in other cancers, they largely failed in glioblastoma(GBM). Here, natural killer (NK) cells from glioma patients show impaired oxidative phosphorylation and mitochondrial complex I activity. Multiomics profiling identified complex I subunit NDUFA9 as a critical mediator of NK cell metabolic fitness. Abundance of NDUFA9+ NK cells informed patient outcome. Ndufa9 knockout in NK cells compromised mitochondrial function, anti-tumor efficacy, and memory-like phenotype of NK cells by triggering a metabolic reprogramming toward glutamine dependence. Decreased α-ketoglutarate(α-KG)/succinate ratio in Ndufa9-deficient NK cells mediated widespread epigenetic reprogramming through inducing transcriptionally repressive histone mark H3K27me3 on key immune function genes. Resveratrol-mediated NDUFA9 activation or its overexpression enhanced NK cell anti-GBM function by restoring complex I activity. Together, these findings reveal the critical role of mitochondrial complex I activity in NK cells and highlight its potential as an actionable target to enhance NK cell-based immunotherapy for GBM patients.